China Reports One-Third Drop In Hep B Vaccinations Following Scandal
This article was originally published in PharmAsia News
Executive Summary
China authorities report a 30% drop in vaccinations against hepatitis B in the wake of a scandal involving the three primary producers of the vaccine.